Research map: Prospective evaluation of a pilot implementation of liver health checks in primary care in England

Back to the article

Papers in this map

  1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature · Mary Eugenia Rinella · 2023 · 3201 citations · Cited by this paper
  2. Dispelling myths and misconceptions of constipation with a focus on stimulant laxatives · 2026 · Related
  3. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease · Mary Eugenia Rinella · 2023 · 2555 citations · Cited by this paper
  4. Update on management of non-pedunculated colonic neoplasia · 2026 · Related
  5. Global burden of liver disease: 2023 update · Harshad C. Devarbhavi · 2023 · 2217 citations · Cited by this paper
  6. No association between time to endoscopy and perforation or aspiration pneumonia in oesophageal food bolus impaction: a multicentre retrospective cohort study · 2026 · Related
  7. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update · Annalisa Berzigotti · 2021 · 1896 citations · Cited by this paper
  8. Response to the letter: "Methodological considerations in assessing guideline adherence in ERCP practice for common bile duct stones" · 2026 · Related
  9. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease · Stuart McPherson · 2010 · 958 citations · Cited by this paper
  10. Frontiers in the management of acute severe ulcerative colitis: current best practice and future directions · 2026 · Related
  11. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis · Stuart McPherson · 2016 · 945 citations · Cited by this paper
  12. Best practice in delivering live endoscopy events in 2026 and beyond · 2026 · Related
  13. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis · Jingxuan Quek · 2022 · 744 citations · Cited by this paper
  14. Third space endoscopy in 2026 and beyond · 2026 · Related
  15. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis · Roger T. Williams · 2014 · 608 citations · Cited by this paper
  16. Faecal calprotectin predicts corticosteroid non-responsiveness in patients with immune checkpoint inhibitor colitis · 2026 · Related
  17. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) · 2024 · 461 citations · Cited by this paper
  18. Management of neoplasia in inflammatory bowel disease · 2026 · Related
  19. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease · Ankur Srivastava · 2019 · 448 citations · Cited by this paper
  20. Practical framework for implementing a starch- and sucrose-reduced diet using Australian national food composition data · 2026 · Related
  21. Natural history and progression of metabolic dysfunction-associated steatotic liver disease · Hannes Hagström · 2024 · 299 citations · Cited by this paper
  22. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population · Isabel Graupera · 2021 · 294 citations · Cited by this paper
  23. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease · Myriam Alexander · 2018 · 283 citations · Cited by this paper
  24. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease · Maria Kjærgaard · 2023 · 240 citations · Cited by this paper
  25. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values · Salvatore Petta · 2016 · 216 citations · Cited by this paper
  26. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease · Μargarita Papatheodoridi · 2020 · 214 citations · Cited by this paper
  27. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia · Miquel Serra‐Burriel · 2019 · 166 citations · Cited by this paper
  28. Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care · John Dillon · 2019 · 89 citations · Cited by this paper
  29. Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group · Stuart McPherson · 2022 · 77 citations · Cited by this paper
  30. Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review · Kushala W. M. Abeysekera · 2022 · 60 citations · Cited by this paper
  31. Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease · Terry Cheuk‐Fung Yip · 2025 · 58 citations · Cited by this paper
  32. Screening for advanced liver fibrosis due to metabolic dysfunction-associated steatotic liver disease alongside retina scanning in people with type 2 diabetes: a cross-sectional study · Andrea Lindfors · 2024 · 33 citations · Cited by this paper
  33. LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries · Isabel Graupera · 2022 · 31 citations · Cited by this paper
  34. Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study · Isabel Graupera · 2026 · 26 citations · Cited by this paper
  35. Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the community · Camilla Dalby Hansen · 2025 · 23 citations · Cited by this paper
  36. Screening for advanced steatotic liver disease · Stine Johansen · 2025 · 19 citations · Cited by this paper
  37. Increasing engagement with liver disease management across the UK: a follow-up cross-sectional survey · Helen Jarvis · 2024 · 8 citations · Cited by this paper
  38. Recording of Alcohol Use Disorder in Electronic Health Records: Developing a Recommended Codelist for Research · Sarah Cook · 2024 · 8 citations · Cited by this paper
  39. Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary–secondary care interface · Stuart McPherson · 2023 · 7 citations · Cited by this paper

Source: OpenAlex (CC0)